Studying the effects of polycyclic aromatic hydrocarbons on peripheral arterial disease in the United States

Science of the Total Environment

Volumn 461-462, Issue , 2013, Pages 341-347

  Xu, Xiaohui ^a   Hu, Hui ^a   Kearney, Gregory D ^b   Kan, Haidong ^c   Sheps, David S ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

^c FUDAN UNIVERSITY   (China)

Author keywords

Environmental exposure; NHANES; OH PAHs; Peripheral arterial disease (PAD); Polycyclic aromatic hydrocarbons (PAHs)

Indexed keywords

ENVIRONMENTAL EXPOSURE; NHANES; OH-PAHS; PERIPHERAL ARTERIAL DISEASE; POLYCYCLIC AROMATIC HYDROCARBONS (PAHS);

COAL COMBUSTION; LOGISTICS; METABOLITES; REGRESSION ANALYSIS; THERMAL PROCESSING (FOODS);

POLYCYCLIC AROMATIC HYDROCARBONS;

1 HYDROXYNAPHTHALENE; 1 HYDROXYPHENANTHRENE; 1 HYDROXYPYRENE; 2 FLUORENOL; 2 HYDROXYPHENANTHRENE; 2 NAPHTHOL; 3 HYDROXYFLUORENE; 3 HYDROXYPHENANTHRENE; FLUORENE DERIVATIVE; NAPHTHALENE DERIVATIVE; PHENANTHRENE DERIVATIVE; POLYCYCLIC AROMATIC HYDROCARBON; PYRENE DERIVATIVE; UNCLASSIFIED DRUG;

CARDIOVASCULAR DISEASE; DISEASE INCIDENCE; DISEASE PREVALENCE; ENVIRONMENTAL FACTOR; FLUORINE; HEALTH GEOGRAPHY; HEALTH RISK; LOGISTICS; METABOLITE; PAH; REGRESSION ANALYSIS; RISK ASSESSMENT;

ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PREVALENCE; PRIORITY JOURNAL; SMOKING; UNITED STATES;

1-HYDROXYNAPHTHALENE; 1-HYDROXYPHENANTHRENE; 1-HYDROXYPYRENE; 1-NAP; 1-PHEN; 1-PYR; 2-FLUO; 2-HYDROXYFLUORENE; 2-HYDROXYNAPHTHALENE; 2-HYDROXYPHENANTHRENE; 2-NAP; 2-PHEN; 3-FLUO; 3-HYDROXYFLUORENE; 3-HYDROXYPHENANTHRENE; 3-PHEN; ABI; ADJUSTED ODDS RATIOS; ANKLE-BRACHIAL INDEX; AORS; CARDIOVASCULAR DISEASE; CIS; CONFIDENCE INTERVALS; CVD; ENVIRONMENTAL EXPOSURE; MONOHYDROXY URINARY METABOLITES OF PAHS; NHANES; ODDS RATIOS; OH-PAHS; ORS; PAD; PAHS; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL ARTERIAL DISEASE (PAD); POLYCYCLIC AROMATIC HYDROCARBONS; POLYCYCLIC AROMATIC HYDROCARBONS (PAHS); THE NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY;

BIOLOGICAL MARKERS; ENVIRONMENTAL EXPOSURE; HUMANS; LOGISTIC MODELS; NUTRITION SURVEYS; PERIPHERAL ARTERIAL DISEASE; POLYCYCLIC HYDROCARBONS, AROMATIC; UNITED STATES;

UNITED STATES;

NICOTIANA TABACUM;

EID: 84878902993     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.04.089     Document Type: Article

References (40)

1. Albert R.E., Vanderlaan M., Burns F.J., Nishizumi M. Effect of carcinogens on chicken atherosclerosis. Cancer Res 1977, 37:2232-2235.
2. Belch J.J., Topol E.J., Agnelli G., Bertrand M., Califf R.M., Clement D.L., et al. Critical issues in peripheral arterial disease detection and management: a call to action. Arch Intern Med 2003, 163:884-892.
3. Benditt E.P., Benditt J.M. Evidence for a monoclonal origin of human atherosclerotic plaques. Proc Natl Acad Sci U S A 1973, 70:1753-1756.
4. Bentsen R.K., Halgard K., Noto H., Daae H.L., Ovrebo S. Correlation between urinary 1-hydroxypyrene and ambient air pyrene measured with an inhalable aerosol sampler and a total dust sampler in an electrode paste plant. Sci Total Environ 1998, 212:59-67.
5. Binkova B., Smerhovsky Z., Strejc P., Boubelik O., Stavkova Z., Chvatalova I., et al. DNA-adducts and atherosclerosis: a study of accidental and sudden death males in the Czech Republic. Mutat Res 2002, 501:115-128.
6. Burstyn I., Kromhout H., Partanen T., Svane O., Langard S., Ahrens W., et al. Polycyclic aromatic hydrocarbons and fatal ischemic heart disease. Epidemiology 2005, 16:744-750.
7. CDC Lower extremity disease procedures manual 2002, CDC.
8. CDC Laboratory procedure manual analyte monohydroxy polycyclic aromatic hydrocarbons 2009, CDC.
9. CDC Questionnaires, datasets and related documentation. National Health and Nutrition Examination Survey 2013, CDC, http://www.cdc.gov/nchs/nhanes.htm.
10. Curfs D.M., Knaapen A.M., Pachen D.M., Gijbels M.J., Lutgens E., Smook M.L., et al. Polycyclic aromatic hydrocarbons induce an inflammatory atherosclerotic plaque phenotype irrespective of their DNA binding properties. FASEB J 2005, 19:1290-1292.
11. EPA Fluorene Atlanta, GA. http://www.epa.gov/osw/hazard/wastemin/minimize/factshts/flourene.pdf.
12. EPA Phenanthrene Atlanta, GA. http://www.epa.gov/osw/hazard/wastemin/minimize/factshts/phenanth.pdf.
13. Everett C.J., King D.E., Player M.S., Matheson E.M., Post R.E., Mainous A.G. Association of urinary polycyclic aromatic hydrocarbons and serum C-reactive protein. Environ Res 2010, 110:79-82.
14. Franco S.S., Nardocci A.C., Gunther W.M. PAH biomarkers for human health risk assessment: a review of the state-of-the-art. Cad Saude Publica 2008, 24(Suppl. 4):s569-s580.
15. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001, 286:1317-1324.
16. Hussein A.A., Uno K., Wolski K., Kapadia S., Schoenhagen P., Tuzcu E.M., et al. Peripheral arterial disease and progression of coronary atherosclerosis. J Am Coll Cardiol 2011, 57:1220-1225.
17. Iwano S., Asanuma F., Nukaya M., Saito T., Kamataki T. CYP1A1-mediated mechanism for atherosclerosis induced by polycyclic aromatic hydrocarbons. Biochem Biophys Res Commun 2005, 337:708-712.
18. Iwano S., Shibahara N., Saito T., Kamataki T. Activation of p53 as a causal step for atherosclerosis induced by polycyclic aromatic hydrocarbons. FEBS Lett 2006, 580:890-893.
19. Kim E.S., Wattanakit K., Gornik H.L. Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk. Cleve Clin J Med 2012, 79:651-661.
20. Levey A.S., Coresh J., Greene T., Stevens L.A., Zhang Y.L., Hendriksen S., et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006, 145:247-254.
21. Li Z., Romanoff L.C., Trinidad D.A., Hussain N., Jones R.S., Porter E.N., et al. Measurement of urinary monohydroxy polycyclic aromatic hydrocarbons using automated liquid-liquid extraction and gas chromatography/isotope dilution high-resolution mass spectrometry. Anal Chem 2006, 78:5744-5751.
22. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation 2002, 105:1135-1143.
23. McClean M.D., Rinehart R.D., Ngo L., Eisen E.A., Kelsey K.T., Wiencke J.K., et al. Urinary 1-hydroxypyrene and polycyclic aromatic hydrocarbon exposure among asphalt paving workers. Ann Occup Hyg 2004, 48:565-578.
24. McDermott M.M., Greenland P., Liu K., Guralnik J.M., Criqui M.H., Dolan N.C., et al. Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA 2001, 286:1599-1606.
25. McGrath T.E., Wooten J.B., Geoffrey Chan W., Hajaligol M.R. Formation of polycyclic aromatic hydrocarbons from tobacco: the link between low temperature residual solid (char) and PAH formation. Food Chem Toxicol 2007, 45:1039-1050.
26. Mumtaz M.M., George J.D., Gold K.W., Cibulas W., DeRosa C.T. ATSDR evaluation of health effects of chemicals. IV. Polycyclic aromatic hydrocarbons (PAHs): understanding a complex problem. Toxicol Ind Health 1996, 12:742-971.
27. Newman A.B., Siscovick D.S., Manolio T.A., Polak J., Fried L.P., Borhani N.O., et al. Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group. Circulation 1993, 88:837-845.
28. Patel V.B., Robbins M.A., Topol E.J. C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. Cleve Clin J Med 2001, 68(521-524):527-534.
29. Pessah-Rasmussen H., Stavenow L., Xu C.B., Berglund A. Increased smooth muscle cell proliferation by dimethylbenzanthracene is correlated to variations in activity of ornithine decarboxylase but not arylhydrocarbonhydroxylase. Artery 1991, 18:240-255.
30. Pope C.A., Burnett R.T., Turner M.C., Cohen A., Krewski D., Jerrett M., et al. Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: shape of the exposure-response relationships. Environ Health Perspect 2011, 119:1616-1621.
31. Ramos K.S., Moorthy B. Bioactivation of polycyclic aromatic hydrocarbon carcinogens within the vascular wall: implications for human atherogenesis. Drug Metab Rev 2005, 37:595-610.
32. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
33. Shimada T., Hayes C.L., Yamazaki H., Amin S., Hecht S.S., Guengerich F.P., et al. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1. Cancer Res 1996, 56:2979-2984.
34. Stavenow L., Pessah-Rasmussen H. Effects of polycyclic aromatic hydrocarbons on proliferation, collagen secretion and viability of arterial smooth muscle cells in culture. Artery 1988, 15:94-108.
35. Thirman M.J., Albrecht J.H., Krueger M.A., Erickson R.R., Cherwitz D.L., Park S.S., et al. Induction of cytochrome CYPIA1 and formation of toxic metabolites of benzo[a]pyrene by rat aorta: a possible role in atherogenesis. Proc Natl Acad Sci U S A 1994, 91:5397-5401.
36. Vanrooij J.G., Bodelier-Bade M.M., De Looff A.J., Dijkmans A.P., Jongeneelen F.J. Dermal exposure to polycyclic aromatic hydrocarbons among primary aluminium workers. Med Lav 1992, 83:519-529.
37. Xu X., Cook R.L., Ilacqua V.A., Kan H., Talbott E.O., Kearney G. Studying associations between urinary metabolites of polycyclic aromatic hydrocarbons (PAHs) and cardiovascular diseases in the United States. Sci Total Environ 2010, 408:4943-4948.
38. Yao S.T., Hobbs J.T., Irvine W.T. Ankle systolic pressure measurements in arterial disease affecting the lower extremities. Br J Surg 1969, 56:676-679.
39. Zhang Y.J., Weksler B.B., Wang L., Schwartz J., Santella R.M. Immunohistochemical detection of polycyclic aromatic hydrocarbon-DNA damage in human blood vessels of smokers and non-smokers. Atherosclerosis 1998, 140:325-331.
40. Zhang F., Li L., Krafft T., Lv J., Wang W., Pei D. Study on the association between ambient air pollution and daily cardiovascular and respiratory mortality in an urban district of Beijing. Int J Environ Res Public Health 2011, 8:2109-2123.